| |
|
|
|
TRACON Pharmaceuticals Inc.  
|
|
1.04 0.07 (0.07%) |
02-21 14:35 |
|
Open: |
0.9882 |
Pre close: |
0.9702 |
Target:
|
1.40 
|
|
High: |
1.08 |
Low: |
0.96 |
Resistance:
|
1.20
1.40
|
|
Volume: |
366,400 |
Market Cap: |
31M |
Support:
|
0.93
0.76
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.00
|
MACD |
MACD(12,26):
|
0.03 |
|
MA(20): |
0.96 |
Signal(12,26,9): |
0.03 |
|
MA(100): |
1.22  |
Stochastic Oscillator |
%K(14,3):
|
57.38 |
|
MA(250): |
1.99 |
%D(3): |
55.77 |
|
Average Volume(K) |
3-Month: |
36535
|
52-Week |
High:
|
3.20 |
|
10-Days: |
26589 |
Low: |
0.50 |
|
RSI |
RSI(14):
|
55.70 |
Change(%): |
-50.5 |
|
Financials, Statistics and Valuation |
|
EPS |
-1.460 |
Return on Equity (ttm) |
-134.6 |
Shares Out. (M) |
29.87 |
|
EPS Est. Current Year |
-1.570 |
Return on Assets (ttm) |
-79.0 |
Shares Float (M) |
29.64 |
|
EPS Est. Next Year |
-1.830 |
PEG Ratio |
0.00 |
% Held by Insiders |
0.00 |
|
EPS Est. Next Quarter |
-0.490 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
60.00 |
|
Forward EPS |
-1.527 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
1.120 |
EBITDA (p.s.) |
0.000 |
P/E |
-0.71 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
0.93 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-24.97 |
P/S |
238959984.00 |
|
Operating Margin |
-1112.10 |
Levered Free Cash Flow
(M) |
-12.58 |
P/CF |
-1.24 |
|
|
|
|
|
|
